At a Morgan Stanley investor conference on Tuesday, UBS Group CFO Todd Tuckner directly addressed two significant structural challenges confronting the bank. His core message was clear: UBS is aware of its vulnerabilities and has plans to manage them, at least for the immediate future.
Capital Regulation Looms Large
The most pressing area of uncertainty stems from upcoming regulatory decisions. The Swiss government is expected to rule in April on the amount of additional capital UBS will be required to hold under new rules enacted following the collapse of Credit Suisse. Tuckner indicated that clarity should emerge “within a few weeks.” UBS continues to lobby for these requirements to be moderated.
The outcome will significantly influence the bank’s capacity for shareholder returns. For 2026, UBS has outlined a share repurchase program worth approximately $3 billion. Furthermore, the Annual General Meeting on April 15 is set to vote on a proposed dividend of $1.10 per share, which would represent a 22% increase over the prior year.
Zero-Rate Environment Squeezes Swiss Operations
Separately, Tuckner highlighted the persistent pressure on the bank’s domestic retail business. The Swiss National Bank’s policy rate of 0% continues to compress net interest income, making it difficult for the Swiss unit to achieve its cost-income ratio target by the end of 2026. For the group as a whole, however, UBS reaffirmed its financial targets. The diversification provided by its global wealth management, investment bank, and asset management divisions helps offset margin pressure in its home market.
Should investors sell immediately? Or is it worth buying UBS?
On the topic of private credit, the CFO expressed a measured confidence. Despite growing sector concerns over valuations and transparency—concerns amplified by insolvencies such as that of automotive supplier First Brands—Tuckner characterized the bank’s exposure as manageable.
Solid Fundamentals Contrast with Share Price Weakness
These strategic discussions are set against a backdrop of robust underlying performance. In 2025, UBS reported a net profit of $7.8 billion, while group invested assets surpassed $7 trillion for the first time. Cumulative cost savings from the integration of Credit Suisse reached $10.7 billion.
Nevertheless, the bank’s shares have faced headwinds, trading roughly 17% lower since the start of the year and remaining below their January peak. The stock is hovering just under its 200-day moving average, a technical level that underscores how heavily the debate over capital regulation is weighing on its valuation. The upcoming AGM on April 15 and the anticipated government decision will prove critical in determining whether the firm’s strong operational foundation can finally outweigh the uncertainty surrounding its future capital requirements.
Ad
UBS Stock: Buy or Sell?! New UBS Analysis from March 18 delivers the answer:
The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 18.
UBS: Buy or sell? Read more here...
